Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Mitochondrial mutation m.3243A>G associates with insulin resistance in non-diabetic carriers

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Gluco-metabolic effects of oral and intravenous alcohol administration in men

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cross-sectional analysis of sleep hours and quality with sex hormones in men

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Blood pressure in 3-year-old girls associates inversely with umbilical cord serum 25-hydroxyvitamin D: an Odense Child Cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Fat oxidation is impaired during exercise in lipin-1 deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIM: This case-control study aimed to examine impairments in glucose metabolism in non-diabetic carriers of the mitochondrial mutation m.3243A>G by evaluating insulin secretion capacity and sensitivity.

METHODS: Glucose metabolism was investigated in 23 non-diabetic m.3243A>G carriers and matched healthy controls with an extended 4-hour oral glucose tolerance test (OGTT). Insulin sensitivity index and acute insulin response were estimated on basis of the OGTT. This was accompanied by examination of body composition by Dual-energy X-ray Absorptiometry (DXA), maximum aerobic capacity, and a Recent Physical Activity Questionnaire (RPAQ).

RESULTS: Fasting p-glucose, s-insulin and s-c-peptide levels did not differ between m.3243A>G carriers and controls. Insulin sensitivity index (BIGTT-S1) was significantly lower in the m.3243A>G carriers, but there was no difference in the acute insulin response between groups. P-lactate levels were higher in carriers throughout the OGTT. VO2max, but not BMI, waist and hip circumferences, lean and fat body mass %, MET or grip strength, was lower in mutation carriers. BIGTT-S1 remained lower in mutation carriers after adjustment for multiple confounding factors including VO2max in regression analyses.

CONCLUSIONS: Glucose metabolism in m.3243A>G carriers was characterized by reduced insulin sensitivity, which could represent the earliest phase in the pathogenesis of m.3243A>G-associated diabetes.

Original languageEnglish
JournalEndocrine Connections
Pages (from-to)829-837
ISSN2049-3614
DOIs
Publication statusPublished - 1 May 2019

ID: 58155781